EP2362905A4 - Procédé d'analyse de composés contre le cancer du poumon ou de l' sophage - Google Patents

Procédé d'analyse de composés contre le cancer du poumon ou de l' sophage

Info

Publication number
EP2362905A4
EP2362905A4 EP09821729A EP09821729A EP2362905A4 EP 2362905 A4 EP2362905 A4 EP 2362905A4 EP 09821729 A EP09821729 A EP 09821729A EP 09821729 A EP09821729 A EP 09821729A EP 2362905 A4 EP2362905 A4 EP 2362905A4
Authority
EP
European Patent Office
Prior art keywords
lung
screening method
esophageal cancer
cancer compounds
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09821729A
Other languages
German (de)
English (en)
Other versions
EP2362905A1 (fr
Inventor
Yusuke Nakamura
Yataro Daigo
Takuya Tsunoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of EP2362905A1 publication Critical patent/EP2362905A1/fr
Publication of EP2362905A4 publication Critical patent/EP2362905A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
EP09821729A 2008-10-24 2009-08-24 Procédé d'analyse de composés contre le cancer du poumon ou de l' sophage Withdrawn EP2362905A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19726308P 2008-10-24 2008-10-24
PCT/JP2009/004054 WO2010047028A1 (fr) 2008-10-24 2009-08-24 Procédé d'analyse de composés contre le cancer du poumon ou de l'œsophage

Publications (2)

Publication Number Publication Date
EP2362905A1 EP2362905A1 (fr) 2011-09-07
EP2362905A4 true EP2362905A4 (fr) 2012-07-04

Family

ID=42119085

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09821729A Withdrawn EP2362905A4 (fr) 2008-10-24 2009-08-24 Procédé d'analyse de composés contre le cancer du poumon ou de l' sophage

Country Status (3)

Country Link
EP (1) EP2362905A4 (fr)
JP (1) JP2012506236A (fr)
WO (1) WO2010047028A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109355394A (zh) * 2018-12-28 2019-02-19 江苏省人民医院（南京医科大学第附属医院） 癌-睾丸抗原cdca5作为食管鳞癌预后标志物及治疗靶点

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002086443A2 (fr) * 2001-04-18 2002-10-31 Protein Design Labs, Inc Procedes de diagnostic du cancer du poumon, compositions et procedes de criblage de modulateurs du cancer du poumon
WO2002102310A2 (fr) * 2001-06-15 2002-12-27 Incyte Genomics, Inc. Proteines associees a la croissance, la differenciation et la mort de cellules
WO2009028581A1 (fr) * 2007-08-24 2009-03-05 Oncotherapy Science, Inc. Gènes se rapportant au cancer, cdca5, epha7, stk31 et wdhd1
WO2009131366A2 (fr) * 2008-04-21 2009-10-29 한국생명공학연구원 Cdca5 en tant que marqueur diagnostique et agent thérapeutique pour le cancer gastrique ou le cancer colorectal

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002086443A2 (fr) * 2001-04-18 2002-10-31 Protein Design Labs, Inc Procedes de diagnostic du cancer du poumon, compositions et procedes de criblage de modulateurs du cancer du poumon
WO2002102310A2 (fr) * 2001-06-15 2002-12-27 Incyte Genomics, Inc. Proteines associees a la croissance, la differenciation et la mort de cellules
WO2009028581A1 (fr) * 2007-08-24 2009-03-05 Oncotherapy Science, Inc. Gènes se rapportant au cancer, cdca5, epha7, stk31 et wdhd1
WO2009131366A2 (fr) * 2008-04-21 2009-10-29 한국생명공학연구원 Cdca5 en tant que marqueur diagnostique et agent thérapeutique pour le cancer gastrique ou le cancer colorectal

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 2 April 2003 (2003-04-02), "Lung cancer-associated polypeptide #46.", XP002674894, retrieved from EBI accession no. GSP:ABU56453 Database accession no. ABU56453 *
DATABASE Geneseq [online] 26 June 2003 (2003-06-26), "Human CGDD-18 protein.", XP002674893, retrieved from EBI accession no. GSP:AAE36187 Database accession no. AAE36187 *
DATABASE Geneseq [online] 30 April 2009 (2009-04-30), "Human CDCA5 protein sequence, SEQ ID 2.", XP002674892, retrieved from EBI accession no. GSP:AWH78695 Database accession no. AWH78695 *
NGUYEN MINH-HUE ET AL: "Phosphorylation and Activation of Cell Division Cycle Associated 5 by Mitogen-Activated Protein Kinase Play a Crucial Role in Human Lung Carcinogenesis", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 70, no. 13, 1 July 2010 (2010-07-01), pages 5337 - 5347, XP009158764, ISSN: 0008-5472, [retrieved on 20100615], DOI: 10.1158/0008-5472.CAN-09-4372 *
RANKIN SUSANNAH ET AL: "Sororin, a substrate of the anaphase-promoting complex, is required for sister chromatid cohesion in vertebrates", MOLECULAR CELL, CELL PRESS, CAMBRIDGE, MA, US, vol. 18, no. 2, 1 April 2005 (2005-04-01), pages 185 - 200, XP002608175, ISSN: 1097-2765 *
SCHMITZ ET AL: "Sororin Is Required for Stable Binding of Cohesin to Chromatin and for Sister Chromatid Cohesion in Interphase", CURRENT BIOLOGY, CURRENT SCIENCE, GB, vol. 17, no. 7, 2 April 2007 (2007-04-02), pages 630 - 636, XP022009298, ISSN: 0960-9822, DOI: 10.1016/J.CUB.2007.02.029 *
See also references of WO2010047028A1 *

Also Published As

Publication number Publication date
WO2010047028A1 (fr) 2010-04-29
JP2012506236A (ja) 2012-03-15
EP2362905A1 (fr) 2011-09-07

Similar Documents

Publication Publication Date Title
EP2064349A4 (fr) Procedes de depistage du cancer gastro-intestinal
EP2285958A4 (fr) Procédé de synthèse de variants de polynucléotides
IL206195A0 (en) Method of treating erythropoietin hyporesponsive anemias
ZA201103032B (en) Method of synthesizing macrolide compounds
PL2376507T3 (pl) Sposób otrzymywania hydroksymetylofosfonianów
PT3106874T (pt) Método para a deteção de cancro
EP2174912A4 (fr) Procédé de traitement d'un composé de cuivre-arsenic
GB0711697D0 (en) Method of manufacture
EP2132570A4 (fr) Procédé de criblage
EP2295564A4 (fr) Composition et procédé de détermination du cancer de l' sophage
IL206845A0 (en) Method of synthesizing tetrahydrobiopterin
EP2428584A4 (fr) Procédé de détection de tumeur colorectale
ZA201002953B (en) Method of making mashable potatoes
EP2233548A4 (fr) Procédé de production de ferrocoke
IL218230A0 (en) Method of treating cancer
EP2197859A4 (fr) Procédé de production d'un composé à base de benzoxazinone
EP2362905A4 (fr) Procédé d'analyse de composés contre le cancer du poumon ou de l' sophage
EP2211616A4 (fr) Procédé de fabrication de composés imidazoazépinones
EP2509599A4 (fr) Méthode de traitement du cancer du pancréas
EP2271775A4 (fr) Panel de biomarqueurs pour la prédiction d'un cancer colorectal récurrent
EP2246431A4 (fr) Méthode de criblage d'un agent anticancéreux
EP2307573A4 (fr) Procédés pour cribler des composés destinés à traiter le cancer
HK1162856A1 (en) Method of preparing deoxyribofuranose compounds
EP2264462A4 (fr) Procédé de criblage d'un agent thérapeutique pour le cancer
PL2307922T3 (pl) Sposób kontroli elektromagnetycznych terahercowych fal nośnych

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110518

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101ALI20120522BHEP

Ipc: C12N 1/19 20060101ALI20120522BHEP

Ipc: C12Q 1/48 20060101ALI20120522BHEP

Ipc: C12N 15/09 20060101AFI20120522BHEP

Ipc: C12N 5/10 20060101ALI20120522BHEP

Ipc: G01N 33/53 20060101ALI20120522BHEP

Ipc: C12N 1/21 20060101ALI20120522BHEP

Ipc: C12N 1/15 20060101ALI20120522BHEP

Ipc: C07K 14/47 20060101ALI20120522BHEP

Ipc: A61K 38/00 20060101ALI20120522BHEP

Ipc: A61P 35/00 20060101ALI20120522BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

A4 Supplementary search report drawn up and despatched

Effective date: 20120604

18W Application withdrawn

Effective date: 20120626